Circulating endothelial progenitor cells in postmenopausal women with and without coronary artery disease

Climacteric

Volumn 12, Issue 3, 2009, Pages 259-265

  Pelliccia, F ^a,b   Pasceri, V ^a   Cianfrocca, C ^a,b   Vitale, C ^c   Meoni, G ^a   Pristipino, C ^a   Speciale, G ^a   Mercuro, G ^b   Rosano, G ^c  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Coronary Artery Disease; Endothelial Progenitor Cells; Endothelialization; Postmenopausal Women; Stem Cells

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STEM CELL; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED;

ANTIGENS, CD; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES; POSTMENOPAUSE; RECEPTORS, CELL SURFACE; STEM CELLS;

EID: 68949090432     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130802696191     Document Type: Article

References (24)

1. Vitale C, MiceliM, Rosano GM. Gender-specific characteristics of atherosclerosis in menopausal women: Risk factors, clinical course and strategies for prevention. Climacteric 2007;10 (Suppl 2):16-20
2. Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005;36:151-153
3. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967
4. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108:457-463
5. Fadini GP, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: The role of female estrogens. Arterioscler Thromb Vasc Biol 2008;28:997-1004
6. Hoetzer GL, MacEneaney OJ, Irmiger HM, et al. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007;99:46-48
7. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448
8. Fadini GP, de Kreutzenberg SV, Coracina A, et al. Circulating CD34-cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006;27:2247-2255
9. Wang Y, Johnsen HE, Mortensen S, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006;92:768-774
10. Rehman J, Li J, Orschell CM, March KL. Peripheral blood ''endothelial progenitor cells'' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-1169
11. Guven H, Shepherd RM, Bach RG, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48: 1579-1587
12. Waters D, Lesperance J, Craven TE, Hudon G, Gillam LD. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis: Implications for clinical trials. Circulation 1993;87(Suppl II):38-47
13. Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computerassisted quantitation of coronary cineangiograms. Circulation 1985;71:280-288
14. Murphy C, Kanaganayagam GS, Jiang B, et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007;27:936-942
15. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(p) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958
16. Silvestre JS, Gojova A, Brun V, et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003;108: 2839-2842
17. George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005;25:2636-2641
18. Vasa M, Fichtlscher S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-7
19. Hill J, Zalos G, Halcox J, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600
20. Schmidt-Lucke C, Rossig L, Fichtlscheer S, et al. Reduced number of circulating endothelial progenitor cells predict future cardiovascular events. Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987
21. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: The evidence. Climacteric 2007;10(Suppl 1): 19-24
22. Quyyumi AA, Hill JM. Circulating endothelial progenitor cells as novel biological determinants of vascular function and risk. Can J Cardiol 2004;20(Suppl B):44-8B
23. Stauffer BL, Hoetzer GL, Van Guilder GP, Smith DT, Desouza CA. Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol 2005;45:1547-1549
24. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004;18:203-209